.Pharmacolibrary.Drugs.ATC.M.M05BB02

Information

name:RisedronicAcidAndCalciumSequential
ATC code:M05BB02
route:oral
n-compartments1

Risedronic acid and calcium, sequential is a fixed-dose combination medication used to treat and prevent osteoporosis in postmenopausal women at risk for vitamin D and calcium deficiencies. Risedronic acid (risedronate) is a bisphosphonate that inhibits bone resorption, while calcium provides a supplement to maintain bone health. It is approved and in use today for osteoporosis management.

Pharmacokinetics

Pharmacokinetic parameters estimated for typical adult population as no direct sources found for the fixed-dose combination; values are primarily based on risedronic acid (risedronate) data for healthy adults administered orally. Calcium component does not impact risedronate PK if taken sequentially.

References

    Revisions


    Generated at 2025-07-20T18:21:09Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos